Aurobindo Pharma USA Inc Dicyclomine Hydrochloride Capsules, 10 mg Recall
Announced 2026-08-12 · FDA
Aurobindo Pharma USA Inc is recalling Dicyclomine Hydrochloride Capsules, USP, 10 mg, Rx only. Batch DMC125018A, Exp Date 07/2027, with about 6,408 bottles distributed nationwide in the US. The recall is due to shortfill; reports of empty capsules.
| Brand | Aurobindo Pharma USA Inc |
|---|---|
| Product | Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99 |
| Reason | shortfill; reports of empty capsules. |
| Severity | moderate |
| Units affected | 6408 |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any recalled capsules.
- Contact your pharmacy or healthcare provider for guidance on return, refund, or replacement.
- Return or dispose of the recalled product per the pharmacist's or distributor's instructions.
- If you experienced adverse effects, contact your healthcare provider and consider reporting to the FDA MedWatch program.
How to identify the recalled item
| Lot / date codes | Batch # DMC125018A, Exp Date: 07/2027. |
|---|---|
| Lot / date codes | Batch # DMC125018A, Exp Date: 07/2027. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.